companydata.dkcompanydata.dk

River Stone Biotech ApS: Financial statements 2023

CVR: 39126729

Source: annual report 2023, Danish Business Authority

01/01/2023 – 31/12/2023

River Stone Biotech ApS (CVR 39126729) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 3,445,469 and a net result of DKK -72,439,968 compared with DKK -52,037,040 the year before. That is a decrease of 52.9% compared with the year before. Equity in the 2023 report amounted to DKK 14,828,301. The solvency ratio was 66.1%. The company had 22 employees in the financial year.

Gross Profit
DKK 3,445,469
Profit/Loss
DKK -72,439,968
Equity
DKK 14,828,301
Total Assets
DKK 22,440,895
Employees
22

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023-3.4 mio.-72.4 mio.14.8 mio.22
2022-7.3 mio.-52 mio.10.7 mio.22
2021-7.6 mio.-18.8 mio.-9.8 mio.18
2020-2.5 mio.-16.1 mio.8.9 mio.15
2019-692 t.-14.3 mio.10.1 mio.13

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

River Stone Biotech ApS: The 2022 annual report is outJul 14, 2023

River Stone Biotech ApS has published its annual report for 2022. Gross profit came to DKK 7,307,696, and the net result was DKK -52,037,040.

About River Stone Biotech ApS

River Stone Biotech ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2017. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Jørgen Hansen. The board consists of Jørgen Hansen and Paul D. Goldenheim. The company is owned by River Stone Biotech Inc.. The company has 32 employees (2026). In 2025, the company reported a gross profit of DKK 1,169,131 and a net result of DKK -31,204,765 compared with DKK -44,572,973 the year before. Equity in the 2025 report amounted to DKK 7,827,761.

Source: annual report 2025, Danish Business Authority

Other financial years